Aequalis Perform
Device Trauma & Extremities
PDI 03700386937330
General payments
$45,427,917
Research payments
$856,170
Through program year 2025, $45,427,917 in general payments and $856,170 in research payments were reported against Aequalis Perform (Trauma & Extremities).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $11,640,317 | 1,727 |
| 2025 | Research | $117,152 | 43 |
| 2024 | General | $8,394,876 | 1,481 |
| 2024 | Research | $212,519 | 69 |
| 2023 | General | $8,261,162 | 1,076 |
| 2023 | Research | $267,736 | 25 |
| 2022 | General | $9,362,232 | 1,069 |
| 2022 | Research | $195,757 | 22 |
| 2021 | General | $7,769,330 | 664 |
| 2021 | Research | $63,005 | 7 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,017 general · 166 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.